Bionano Genomics Inc (BNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,065 | 14,562 | 3,625 | 9,173 | 8,794 |
| Marketable Securities | 28,782 | 12,876 | 25,606 | 11,302 | 14,160 |
| Receivables | 4,526 | 3,493 | 3,354 | 4,752 | 5,316 |
| Inventories | 7,049 | 8,633 | 9,562 | 11,121 | 14,323 |
| TOTAL | $48,800 | $42,662 | $44,929 | $39,489 | $46,980 |
| Non-Current Assets | |||||
| PPE Net | 16,172 | 17,264 | 18,339 | 19,219 | 19,995 |
| Intangibles | 5,685 | 7,025 | 8,365 | 9,705 | 11,045 |
| Other Non-Current Assets | 8,405 | 9,059 | 6,781 | 8,257 | 9,342 |
| TOTAL | $30,262 | $33,348 | $33,485 | $37,181 | $40,382 |
| Total Assets | $79,062 | $76,010 | $78,414 | $76,670 | $87,362 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,990 | 6,244 | 6,562 | 6,962 | 8,700 |
| Accrued Expenses | 4,706 | 3,405 | 3,937 | 5,641 | 5,883 |
| Other current liabilities | 1,180 | 1,165 | 1,020 | 1,128 | 1,195 |
| TOTAL | $22,977 | $24,178 | $26,408 | $37,344 | $32,950 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,791 | 2,947 | 292 | 412 | 1,993 |
| TOTAL | $6,286 | $6,458 | $3,818 | $3,951 | $5,544 |
| Total Liabilities | $29,263 | $30,636 | $30,226 | $41,295 | $38,494 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,176 | 4,681 | 3,364 | 3,007 | 1,703 |
| Common Shares | 1 | N/A | N/A | N/A | 9 |
| Retained earnings | -711,687 | -703,184 | -696,327 | -693,225 | -673,100 |
| Other shareholders' equity | 6 | -10 | 14 | 27 | 1,534 |
| TOTAL | $49,799 | $45,374 | $48,188 | $35,375 | $48,868 |
| Total Liabilities And Equity | $79,062 | $76,010 | $78,414 | $76,670 | $87,362 |